Compile Data Set for Download or QSAR
Report error Found 21 Enz. Inhib. hit(s) with all data for entry = 13209
TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767016(3-(6-fluoro-1-oxo-4-((4-(piperidin-1- ylmethyl)ben...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767015(3-(6-fluoro-1-oxo-4-((7-(((1R,2S,4R)-1,7,7- trimet...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767034(3-(4-((7-((adamantan-1-yl)amino)heptyl)thio)-6-flu...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767033(3-(4-((7-((adamantan-1- yl)(methyl)amino)heptyl)th...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767030(3-(6-fluoro-1-oxo-4-((7-oxo-7-(piperidin-1- yl)hep...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767029(3-(6-fluoro-4-((3-fluoro-4-(piperidin-1- ylmethyl)...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767032(3-(4-((7-(4,4-difluoropiperidin-1-yl)-7- oxoheptyl...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767031(3-(4-((7-(cyclohexylamino)heptyl)thio)-6- fluoro-1...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767026(3-(6-fluoro-1-oxo-4-((7-(piperidin-1- yl)heptyl)th...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767025(3-(4-((4-((4,4-difluoropiperidin-1- yl)methyl)-3-f...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767028(3-(4-((7-(4,4-difluoropiperidin-1- yl)heptyl)thio)...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767027(3-(4-((4-(2-((adamantan-1- yl)amino)ethyl)benzyl)t...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767022(3-(6-fluoro-4-((8-morpholinooctyl)thio)-1- oxoisoi...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767021(3-(6-fluoro-1-oxo-4-((7-(spiro[3.3]heptan-2- ylami...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767024(3-(4-((8-(diethylamino)octyl)thio)-6-fluoro- 1-oxo...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767023(3-(4-(8-((adamantan-1-yl)amino)octyl)-6- fluoro-1-...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767018(3-(4-((4-((4,4-difluoropiperidin-1- yl)methyl)benz...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767017(3-(6-fluoro-1-oxo-4-((4-((((1R,2S,4R)-1,7,7- trime...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767020(3-(4-((4-((adamantan-1- yl)amino)butyl)thio)-6-flu...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM767019(3-(4-((4-(((adamantan-1-yl)amino)methyl)benzyl)thi...)
Affinity DataIC50: 600nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM65454(Lenalidomide | US9694015, 6.1 | 191732-72-6 | Revl...)
Affinity DataIC50: 2.25E+3nMAssay Description:The specific methods are as follows:1. According to the instructions of the CEREBLON BINDING kits, the compounds of the present invention to be teste...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2025
Entry Details
US Patent